Skip to Content

Tag: C. R. Bard


BD accelerates offerings with Bard

April 25, 2017HME News Staff

FRANKLIN LAKES, N.J., and MURRAY HILL, N.J. - Becton, Dickinson and Company will buy C. R. Bard for $24 billion, the companies announced April 23.The deal builds on BD's position in medication management and infection prevention, and increases its opportunities in fast-growing clinical areas like vascular therapy, according to a press release."Combining with Bard will accelerate our ability to offer more comprehensive, clinically relevant solutions to customers and patients around the globe, creating...

Becton, C. R. Bard, Dickinson, M&A, supplies

Read Full Articlered right arrow icon